Cover Expensive Off-Label Drugs with Cancer Protection Plans

Price: Complimentary

With the introduction of the new Approved Cancer Drug List, cancer patients that receive off-label medication are required to pay upfront without being able to claim from their Integrated Shield Plans (IPs).

Under the new ruling, insurers will not be able to pay for the treatment if the drug used does not fall in the approved list, and the cost of treatment may come up to $20,000 a month.

There are many cancer protection plans in the market. 

More on Cancer Protection

Some are suitable for younger clients, some are suitable for senior clients.

There are also plans for clients who have had cancer in the past and would like to cover for future cost of relapse.

Every client is unique. To ensure that you get the best Cancer Protection Plan suitable for you, schedule a consultation session today!

Disclaimer: The content above, including all information, opinions, and interactive elements, was created by the individual financial consultant. The views expressed are the consultant’s own and do not necessarily reflect the official policy or position of Financial Alliance. Financial Alliance does not guarantee the accuracy or completeness of this content and is not responsible for any errors or omissions. If you believe any information is inaccurate or have other feedback regarding this content, please contact us at feedback@fa.com.sg.

Readers should seek independent, unbiased financial advice that is customised to their specific financial objectives, situation, and needs. This publication has not been reviewed by the Monetary Authority of Singapore.

CONTACT US